{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:49Z","timestamp":1786118629028,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.mjt.0000129047.29136.de","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T14:55:32Z","timestamp":1093964132000},"page":"S1-S8","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Resistance and Impact on Appropriate Antimicrobial Use"],"prefix":"10.1097","volume":"11","author":[{"given":"Ronald J","family":"DeBellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.1996.03530270029027","article-title":"Trends in infectious diseases mortality in the United States.","volume":"275","author":"Pinner","year":"1996","journal-title":"JAMA"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the United States during the 20th century.","volume":"281","author":"Armstrong","year":"1999","journal-title":"JAMA"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/scientificamerican0398-46","article-title":"The challenge of antibiotic resistance.","volume":"278","author":"Levy","year":"1998","journal-title":"Sci Am"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/342885","article-title":"Bacterial contamination of animal feed and its relationship to human foodborne illness.","volume":"35","author":"Crump","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia.","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00006454-199610000-00034","article-title":"Efficacy of amoxicillin\/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility.","volume":"15","author":"Hoberman","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R7-2-20210202","first-page":"214","article-title":"Loracarbef (LY163892) versus amoxicillin\/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.","volume":"14","author":"Zeckel","year":"1992","journal-title":"Clin Ther"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneumoniae.","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R9-2-20210202","first-page":"S19","article-title":"Epidemiology and mechanisms of resistance among respiratory tract pathogens.","volume":"4","author":"Baquero","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(97)00195-8","article-title":"Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.","volume":"29","author":"Thornsberry","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumococcal macrolide resistancemyth or reality?","volume":"44","author":"Amsden","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/344768","article-title":"Widespread use of fluoroquinolones versus emerging resistance in pneumococci.","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.","volume":"34","author":"Lynch","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/374846","article-title":"Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?","volume":"36","author":"Sanchez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/clinids\/15.1.95","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990.","volume":"15","author":"Geslin","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/324525","article-title":"Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.","volume":"34","author":"Thornsberry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong.","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/000992289803701104","article-title":"Current attitudes regarding use of antimicrobial agents: results from physicians and parents focus group discussions.","volume":"37","author":"Barden","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"R23-2-20210202","first-page":"613","article-title":"Antimicrobial selection and length of hospital stay in patients with community-acquired pneumonia.","volume":"9","author":"Trowbridge","year":"2002","journal-title":"J Clin Outcome Manage"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.163.5.601","article-title":"Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use.","volume":"163","author":"Lautenbach","year":"2003","journal-title":"Arch Intern Med"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archinte.163.7.797","article-title":"Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting.","volume":"163","author":"Malcolm","year":"2003","journal-title":"Arch Intern Med"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9343(91)90125-H","article-title":"Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with usual care in a multicenter clinical trial.","volume":"91","author":"Sanders","year":"1991","journal-title":"Am J Med"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archinte.1995.00430120050006","article-title":"Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.","volume":"155","author":"Ramirez","year":"1995","journal-title":"Arch Intern Med"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.310.6991.1360","article-title":"Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial.","volume":"310","author":"Chan","year":"1995","journal-title":"BMJ"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0002-9343(91)90181-V","article-title":"Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.","volume":"91","author":"Paladino","year":"1991","journal-title":"Am J Med"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/ajrccm.153.3.8630553","article-title":"Evaluation of a pneumonia practice guideline in an interventional trial.","volume":"153","author":"Weingarten","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.113.1.142","article-title":"The clinical benefit of in-hospital observation in low-risk pneumonia patients after conversion from parenteral to oral antimicrobial therapy.","volume":"113","author":"Rhew","year":"1998","journal-title":"Chest"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0002-9343(98)00359-3","article-title":"The utility of an in-hospital observation period after discontinuing intravenous antibiotics.","volume":"106","author":"Dunn","year":"1999","journal-title":"Am J Med"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9343(98)00368-4","article-title":"Is an observation period necessary after intravenous antibiotics are changed to oral administration?","volume":"106","author":"Beumont","year":"1999","journal-title":"Am J Med"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(00)00744-0","article-title":"Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.","volume":"110","author":"Dean","year":"2001","journal-title":"Am J Med"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia.","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-200407001-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:19:41Z","timestamp":1786033181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200407001-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":38,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mjt.0000129047.29136.de","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}